Loading organizations...
I2Pure develops a patented platform featuring advanced molecular iodine formulations, creating pure compositions with superior efficacy and reduced toxicity. This technology integrates into solutions, polymers, and coatings for medical devices, antiseptics, and water or food safety products. Its broad-spectrum capabilities effectively target viruses, bacteria, and fungi, offering versatile protection.
Rob and Rob Painter founded I2Pure in 2020, driven by molecular iodine’s inherent potent, broad-spectrum antimicrobial activity without pathogen resistance. This insight revealed opportunity for solutions beyond traditional antibiotics and harsh disinfectants. The founders focused on safely integrating high concentrations of molecular iodine into diverse materials and living tissues.
I2Pure’s technology serves healthcare, manufacturing, and environmental safety sectors, enhancing product integrity and biosafety. The company’s mission is to prevent global pathogenic threats, improving health and reducing bioburdens through its platform. The vision is to expand these non-toxic, biocompatible formulations to neutralize pathogens and biofilms across more applications.
I2 Pure has raised $50K across 1 funding round.
I2 Pure has raised $50K in total across 1 funding round.
I2 Pure has raised $50K across 1 funding round. Most recently, it raised $50K Seed in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2021 | $50K Seed | — | FG Ventures | Announced |
I2Pure is a healthcare technology company that develops patented, non‑toxic *molecular iodine* formulations intended to prevent infections across medical, veterinary, industrial and consumer applications, and it positions those formulations for use in solutions, polymers, coatings and devices to reduce bioburden and improve biosafety[1][2].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech / Health Landscape
Quick Take & Future Outlook
Primary sources used: I2Pure corporate pages (company overview, about, news), product/partner announcement pages and third‑party product listings that summarize technical claims and collaborations[1][2][3][4][6].
I2 Pure has raised $50K in total across 1 funding round.
I2 Pure's investors include FG Ventures.